Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 17 | $5,862,806 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 18 Jun 2024 21:39 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 14 Jun 2024 | Sale | 1,900 | 280 | 532,000 | D |
| 14 Jun 2024 21:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 12 Jun 2024 | Sale | 2,000 | 285 | 570,000 | D |
| 23 May 2024 21:36 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 21 May 2024 | Sale | 1,036 | 231.34 | 239,668 | D |
| 18 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 15 Dec 2023 | Sale | 1,000 | 241 | 241,000 | D |
| 18 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 15 Dec 2023 | Sale | 1,000 | 236 | 236,000 | D |
| 18 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 14 Dec 2023 | Sale | 1,000 | 232 | 232,000 | D |
| 18 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 14 Dec 2023 | Sale | 1,000 | 233 | 233,000 | D |
| 14 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 13 Dec 2023 | Sale | 1,000 | 226 | 226,000 | D |
| 14 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 12 Dec 2023 | Sale | 800 | 219 | 175,200 | D |
| 14 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 13 Dec 2023 | Sale | 1,500 | 225 | 337,500 | D |
| 14 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 12 Dec 2023 | Sale | 500 | 216 | 108,000 | D |
| 02 Mar 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 01 Mar 2023 | Sale | 100 | 276.19 | 27,619 | D |
| 02 Mar 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 01 Mar 2023 | Sale | 1,300 | 275.53 | 358,189 | D |
| 02 Mar 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 01 Mar 2023 | Sale | 1,672 | 274.57 | 459,081 | D |
| 02 Mar 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 01 Mar 2023 | Sale | 1,928 | 273.44 | 527,192 | D |
| 02 Mar 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 28 Feb 2023 | Sale | 4,100 | 272.3 | 1,116,430 | D |
| 02 Mar 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 28 Feb 2023 | Sale | 900 | 271.03 | 243,927 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)